Artificial intelligence continues to influence nearly every industry, and life sciences are no exception. In a recent conversation on the AI and Business podcast, Damien Nero, Head of Data Science in US Medical at Takeda Pharmaceuticals, shared his perspective on how AI is changing the clinical trial landscape. With over 15 years of experience applying machine learning and real-world data to drug development, Nero outlined both the progress already being made and the challenges that still stand in the way of broader transformation. His insights highlight how pharmaceutical leaders can think strategically about deploying AI to balance innovation with operational efficiency.

‍

Discover how eCOA software is reshaping modern clinical trials by enabling decentralized designs, enhancing patient adherence, and optimizing data collection through real-time digital tools. Learn how cloud-based solutions and AI are driving the next evolution in clinical research.

‍